Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines - PubMed (original) (raw)

. 1998 May;13(5):793-802.

doi: 10.1359/jbmr.1998.13.5.793.

Affiliations

• PMID: 9610743
• DOI: 10.1359/jbmr.1998.13.5.793

Free article

Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines

R L Jilka et al. J Bone Miner Res. 1998 May.

Free article

Abstract

Once osteoblasts have completed their bone-forming function, they are either entrapped in bone matrix and become osteocytes or remain on the surface as lining cells. Nonetheless, 50-70% of the osteoblasts initially present at the remodeling site cannot be accounted for after enumeration of lining cells and osteocytes. We hypothesized that the missing osteoblasts die by apoptosis and that growth factors and cytokines produced in the bone microenvironment influence this process. We report that murine osteoblastic MC3T3-E1 cells underwent apoptosis following removal of serum, or addition of tumor necrosis factor (TNF), as indicated by terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling and DNA fragmentation studies. Transforming growth factor-beta and interleukin-6 (IL-6)-type cytokines had antiapoptotic effects because they were able to counteract the effect of serum starvation or TNF. In addition, anti-Fas antibody stimulated apoptosis of human osteoblastic MG-63 cells and IL-6-type cytokines prevented these changes. The induction of apoptosis in MG-63 cells was associated with an increase in the ratio of the proapoptotic protein bax to the antiapoptotic protein bcl-2, and oncostatin M prevented this change. Examination of undecalcified sections of murine cancellous bone revealed the presence of apoptotic cells, identified as osteoblasts by their proximity to osteoid seams and their juxtaposition to cuboidal osteoblasts. Assuming an osteoblast life span of 300 h and a prevalence of apoptosis of 0.6%, we calculated that the fraction that undergo this process in vivo can indeed account for the missing osteoblasts. These findings establish that osteoblasts undergo apoptosis and strongly suggest that the process can be modulated by growth factors and cytokines produced in the bone microenvironment.

PubMed Disclaimer

Similar articles

• Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio.
  Wiren KM, Toombs AR, Semirale AA, Zhang X. Wiren KM, et al. Bone. 2006 May;38(5):637-51. doi: 10.1016/j.bone.2005.10.029. Epub 2006 Jan 18. Bone. 2006. PMID: 16413235
• Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
  Urayama S, Kawakami A, Nakashima T, Tsuboi M, Yamasaki S, Hida A, Ichinose Y, Nakamura H, Ejima E, Aoyagi T, Nakamura T, Migita K, Kawabe Y, Eguchi K. Urayama S, et al. J Lab Clin Med. 2000 Sep;136(3):181-93. doi: 10.1067/mlc.2000.108754. J Lab Clin Med. 2000. PMID: 10985496
• Enamel matrix derivative inhibits TNF-alpha-induced apoptosis in osteoblastic MC3T3-E1 cells.
  He J, King Y, Jiang J, Safavi KE, Spångberg LS, Zhu Q. He J, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Jun;99(6):761-7. doi: 10.1016/j.tripleo.2004.07.022. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005. PMID: 15897865
• Cellular and molecular effects of growth hormone and estrogen on human bone cells.
  Kassem M. Kassem M. APMIS Suppl. 1997;71:1-30. APMIS Suppl. 1997. PMID: 9357492 Review.
• [Apoptosis--basic regulatory mechanism of bone remodeling].
  Rusu T. Rusu T. Rev Med Chir Soc Med Nat Iasi. 2002 Oct-Dec;106(4):674-9. Rev Med Chir Soc Med Nat Iasi. 2002. PMID: 14974209 Review. Romanian.

Cited by

• Regulation of Osteoblast Differentiation by Cytokine Networks.
  Amarasekara DS, Kim S, Rho J. Amarasekara DS, et al. Int J Mol Sci. 2021 Mar 11;22(6):2851. doi: 10.3390/ijms22062851. Int J Mol Sci. 2021. PMID: 33799644 Free PMC article. Review.
• Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual.
  Almeida M, Iyer S, Martin-Millan M, Bartell SM, Han L, Ambrogini E, Onal M, Xiong J, Weinstein RS, Jilka RL, O'Brien CA, Manolagas SC. Almeida M, et al. J Clin Invest. 2013 Jan;123(1):394-404. doi: 10.1172/JCI65910. Epub 2012 Dec 10. J Clin Invest. 2013. PMID: 23221342 Free PMC article.
• The pharmacological effects of morroniside and loganin isolated from Liuweidihuang Wan, on MC3T3-E1 cells.
  Li M, Wang W, Wang P, Yang K, Sun H, Wang X. Li M, et al. Molecules. 2010 Oct 21;15(10):7403-14. doi: 10.3390/molecules15107403. Molecules. 2010. PMID: 20966881 Free PMC article.
• Apoptosis during intramembranous ossification.
  Palumbo C, Ferretti M, De Pol A. Palumbo C, et al. J Anat. 2003 Dec;203(6):589-98. doi: 10.1046/j.1469-7580.2003.00247.x. J Anat. 2003. PMID: 14686694 Free PMC article.
• TGF-beta1 on osteoimmunology and the bone component cells.
  Kasagi S, Chen W. Kasagi S, et al. Cell Biosci. 2013 Jan 15;3(1):4. doi: 10.1186/2045-3701-3-4. Cell Biosci. 2013. PMID: 23321200 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal